Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stratton

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|May 23, 1997
Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidaseJ A Robl, C Q Sun, J Stevenson, et al.
The Lancet. Oncology|November 13, 2018
Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohortTodd M Gibson, Sogol Mostoufi-Moab, Kayla L Stratton, et al.
Oncoimmunology|October 10, 2015
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with <i>Candida</i> skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3William W Greenfield, Shawna L Stratton, Rebecca S Myrick, et al.
European Urology|May 22, 2025
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerMarie-Pier St-Laurent, Parminder Singh, David J McConkey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 VariantKasmintan A Schrader, Kelly L Stratton, Rajmohan Murali, et al.
The Lancet. Oncology|October 5, 2023
Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor StudyCheng Chen, Na Qin, Mingjuan Wang, et al.
The Journal of Urology|April 8, 2015
Gleason 6 Prostate Cancer: Translating Biology into Population HealthScott E Eggener, Ketan Badani, Daniel A Barocas, et al.
Cancer Discovery|April 19, 2026
Therapy-related mutational signatures in subsequent neoplasms among survivors of childhood cancerSamuel W Brady, Michael A Arnold, Mingjuan Wang, et al.
Genome Announcements|November 18, 2017
Genome Sequences of 19 Novel <i>Erwinia amylovora</i> BacteriophagesIan N D Esplin, Jordan A Berg, Ruchira Sharma, et al.
HGG Advances|January 7, 2022
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to TreatmentYu Jiang, Travis J Meyers, Adaeze A Emeka, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|May 23, 1997
Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidaseJ A Robl, C Q Sun, J Stevenson, et al.
The Lancet. Oncology|November 13, 2018
Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohortTodd M Gibson, Sogol Mostoufi-Moab, Kayla L Stratton, et al.
Oncoimmunology|October 10, 2015
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with <i>Candida</i> skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3William W Greenfield, Shawna L Stratton, Rebecca S Myrick, et al.
European Urology|May 22, 2025
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerMarie-Pier St-Laurent, Parminder Singh, David J McConkey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 VariantKasmintan A Schrader, Kelly L Stratton, Rajmohan Murali, et al.
The Lancet. Oncology|October 5, 2023
Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor StudyCheng Chen, Na Qin, Mingjuan Wang, et al.
The Journal of Urology|April 8, 2015
Gleason 6 Prostate Cancer: Translating Biology into Population HealthScott E Eggener, Ketan Badani, Daniel A Barocas, et al.
Cancer Discovery|April 19, 2026
Therapy-related mutational signatures in subsequent neoplasms among survivors of childhood cancerSamuel W Brady, Michael A Arnold, Mingjuan Wang, et al.
Genome Announcements|November 18, 2017
Genome Sequences of 19 Novel <i>Erwinia amylovora</i> BacteriophagesIan N D Esplin, Jordan A Berg, Ruchira Sharma, et al.
HGG Advances|January 7, 2022
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to TreatmentYu Jiang, Travis J Meyers, Adaeze A Emeka, et al.
Pageof 13